Ancient Ayurvedic Formula Triphalaguggul Shows Potent Anti-Arthritis Action in Rat Study

A centuries-old Ayurvedic remedy has delivered striking results in a modern laboratory. Triphalaguggul, a polyherbal formulation combining the three-fruit blend Triphala with the oleo-gum resin guggul, significantly reduced joint inflammation and cartilage damage in rat models of both osteoarthritis and rheumatoid arthritis, according to a study published in the journal Biogerontology. The work, led by Anumita Dey and Pranab Kumar Sahoo of the University of Calcutta together with colleagues at Rajabazar Science College and the Institute of Post Graduate Ayurvedic Education & Research in Kolkata, offers a molecular explanation for why this traditional medicine may ease the burden of two of the world’s most common joint diseases.

The stakes are considerable. Osteoarthritis affects an estimated 7 to 8 percent of the global population, while rheumatoid arthritis invades roughly 0.2 to 1 percent of people worldwide. Both conditions become more prevalent with age, and researchers increasingly view aging itself as an underlying hallmark of arthritis progression. As life expectancy rises and the aged population grows exponentially across the globe, the search for therapies that can protect aging joints has become a central concern of biomedical research, a field known as geroprotection.

Current treatment options leave much to be desired. Non-steroidal anti-inflammatory drugs, the mainstay of symptomatic relief, are widely regarded as a secondary treatment option because of their high cost, inadequate pharmacological action in many patients, and well-documented adverse effects ranging from gastrointestinal bleeding to kidney damage. There is no cure for either osteoarthritis or rheumatoid arthritis, and despite decades of research into their pathogenesis, efficient curable approaches remain challenging. This therapeutic gap has driven a demographic shift toward polyherbal medicines, particularly formulations designed to inhibit pro-inflammatory cytokines, the signaling molecules that drive joint destruction.

Triphalaguggul is precisely such a formulation. Triphala, a balanced combination of the fruits of three plants, has long been used in Indian systems of medicine as a rejuvenating tonic, and prior studies have shown that Triphala herbal extract can suppress inflammatory responses in macrophages and in arthritic rats by inhibiting the NF-κB pathway. Guggul, the resin of Commiphora wightii, contributes guggulsterones and other phytochemicals with documented anti-inflammatory properties. The research team hypothesized that combining these ingredients would target the downregulation of pro-inflammatory cytokines and their signaling pathways, addressing the molecular engine of arthritis rather than merely its symptoms.

To test this, the researchers ran two complementary disease models in rats. Osteoarthritis was induced by intra-articular injection of monosodium iodoacetate, a compound that selectively kills chondrocytes, the cartilage-producing cells of the joint, and thereby mimics the progressive cartilage degradation seen in human osteoarthritis. Rheumatoid arthritis was modeled using complete Freund’s adjuvant, an immunological challenge that triggers chronic, systemic joint inflammation resembling the autoimmune attack characteristic of rheumatoid arthritis. Alongside these efficacy studies, the team conducted toxicological evaluations to establish the safety profile of the formulation.

The results were dramatic. In the osteoarthritis model, Triphalaguggul reduced inflamed knee measurements by 96.15 percent and paw edema by 95.18 percent. Perhaps more importantly, histological examination showed that the treatment helped chondrocytes regrow and rearrange themselves properly within the damaged cartilage, suggesting genuine structural repair rather than simple suppression of swelling. In the rheumatoid arthritis model, blood chemistry markers that typically spike during active disease were brought back into line. Elevated levels of the liver enzymes SGPT and SGOT, alkaline phosphatase, C-reactive protein, and rheumatoid factor were all reinstated to their normal ranges after treatment, with statistical significance at p < 0.05.

The molecular story behind these outcomes centers on three cytokines: interleukin-6, tumor necrosis factor-alpha, and interleukin-1 beta. These pro-inflammatory messengers are central to the pathology of both joint diseases. In osteoarthritis, they drive the catabolic cascade that degrades cartilage matrix; in rheumatoid arthritis, they orchestrate the autoimmune inflammation that erodes bone and synovium. Using enzyme-linked immunosorbent assays, the team showed that levels of all three cytokines, which had risen sharply in the arthritic animals, fell significantly after Triphalaguggul treatment.

Downstream of these cytokines lie two of the most important signaling highways in inflammation biology: the JAK/STAT pathway and the NF-κB pathway. When interleukin-6 or related cytokines bind their receptors, they activate Janus kinase 2, which in turn phosphorylates the transcription factor STAT3, sending it into the nucleus to switch on inflammatory genes. In parallel, the p65 subunit of nuclear factor kappa B translocates to the nucleus to activate another battery of inflammatory genes, including those encoding cytokines themselves, creating a self-amplifying loop. The researchers found that the enhanced expression of phosphorylated JAK2, phosphorylated STAT3, and NF-κB p65 seen in arthritic rats was significantly downregulated after treatment. These findings were validated by two independent techniques, western blotting, which quantifies protein abundance, and immunohistochemistry, which maps protein localization within tissue sections, lending robustness to the conclusion.

By demonstrating that a single polyherbal formulation can simultaneously quiet cytokine production and dampen both major inflammatory signaling cascades, the study positions Triphalaguggul as a candidate geroprotective therapy, one that targets pro-inflammatory cytokines and the JAK/STAT and NF-κB pathways as therapeutic biomarkers of aging-related joint disease. The framing matters: rather than treating osteoarthritis and rheumatoid arthritis as separate problems, the work treats chronic low-grade inflammation as a shared molecular thread running through aging and arthritis alike, and proposes that pulling that thread with a well-characterized herbal mixture could protect against geriatric disease more broadly.

Substantial caveats remain before this ancient formula reaches modern pharmacies. The evidence comes entirely from chemically induced rat models, which reproduce key features of human joint disease but do not capture its full complexity, and dose translation between laboratory animals and humans is a well-known hurdle in preclinical drug development. Human clinical trials, standardization of the formulation, and pharmacokinetic characterization of its active constituents will all be required. Still, the study adds rigorous molecular data to a growing body of literature on traditional herbal medicines, from curcumin to guggulsterones, that modulate exactly the inflammatory pathways targeted by modern biologics. For the millions of people whose aging joints ache with inflammation, the possibility that a validated, affordable, and safe botanical alternative could emerge from a millennium-old prescription is a prospect worth watching closely.

Subject of Research: Anti-arthritic and geroprotective effects of the polyherbal formulation Triphalaguggul on cytokine signaling in rat models of osteoarthritis and rheumatoid arthritis

Article Title: Geroprotective efficacy of Triphalaguggul: a polyherbal formulation against inflammatory disorders through inhibition of pro-inflammatory cytokines as therapeutic biomarkers

Article References: Dey, A., Datta, S., Gupta, M., Chattapadhyay, H., & Sahoo, P. K. (2026). Geroprotective efficacy of Triphalaguggul: a polyherbal formulation against inflammatory disorders through inhibition of pro-inflammatory cytokines as therapeutic biomarkers. Biogerontology, 27(5), Article 176. https://doi.org/10.1007/s10522-026-10519-9

Image Credits: AI Generated

DOI: 10.1007/s10522-026-10519-9

Keywords: Triphalaguggul, osteoarthritis, rheumatoid arthritis, pro-inflammatory cytokines, JAK/STAT pathway, NF-κB, Ayurveda, guggul, Triphala, geroprotection, rat models, IL-6